Keywords
Child
Adolescent
Epidemiology descriptive
Diagnosis
How to Cite
Abstract
Palmas is the most hyperendemic capital for leprosy in Brazil, with active transmission and persistence of transmission focus. The objective of this study was to describe the clinical and epidemiological profile of leprosy in children younger than 15 years evaluated by Complementary Diagnostic Investigation Protocol for children under 15 years of age (PCID <15 years between 2016 and 2017 was carried out. A total of 71 cases were evaluated by protocol. Of these, 83.10% had affected nerves, 92.96% multibacillary, 38.03% with degree 1 or 2 of disability. The OMP score ranged from 1 to 6 in 22.54% of the cases. The time of onset of the signs and symptoms was from 6 months to 1 year in 35.21% of the cases. 73.24% had people with skin problems in the family; 87.32% people with leprosy in the family. Between 1 and 26 lesions / skin patches were observed in 88.73% with loss of sensitivity. The presence of 1 or 2 BCG scars was recorded in 90.14% of the cases. The search for confirmed case contacts and timely evaluation is crucial for the early diagnosis of leprosy in children and adolescents, since only then it will be possible to reduce the sources of infection, interrupt the transmission chain, prevent physical, psychological and social disabilities.References
World Health Organization. Global leprosy update, 2018: reducing the disease burden due to leprosy. Wkly Epidemiol Rec. 2018;93(35):445-56.
Alencar CH, Ramos AN Jr, Santos ES, Richter J, Heukelbach J. Clusters of leprosy transmission and of late diagnosis in a highly endemic area in Brazil: focus on different spatial analysis approaches. Trop Med Int Health, 2012;17(4):518-25. doi: 10.1111 / j.1365-3156.2011.02945.x.
Monteiro LD, Martins-Melo FR, Brito AL, Lima MS, Alencar CH, Heukelbach J. Tendências da hanseníase no Tocantins, um estado hiperendêmico do Norte do Brasil, 2001-2012. Cad. Saúde Pública, 2015;31(5):971-80.
Ministério da Saúde (BR). Secretaria de Vigilância em Saúde. Departamento de Vigilância das Doenças Transmissíveis. Guia prático sobre a hanseníase [recurso eletrônico]. Brasília: Ministério da Saúde; 2018.
World Health Organization. Global leprosy strategy: accelerating towards a leprosy-free world. Switzerland: WHO; 2016.
Monteiro LD, Lopes LSO, Santos PR, Rodrigues ALM, Bastos WM, Barreto JA. Tendências da hanseníase após implementação de um projeto de intervenção em uma capital da Região Norte do Brasil, 2002-2016. Cad Saúde Pública. 2018;34(11):e00007818.
Monteiro LD, Alencar CH, Barbosa JC, Novaes CCBS, Silva RCP, Herkelbach J. Pós-alta de hanseníase: limitação de atividade e participação social em área hiperendêmica do Norte do Brasil. Rev Bras Epidemiol. 2014;17(1):91-104.
World Health Organization. Leprosy: world focused on ending transmission among children. Switzerland: WHO; 2018.
Lockwood DN, Shetty V, Penna GO. Hazards of setting targets to eliminate disease: lessons from the leprosy elimination campaign. BMJ. 2014;348:g1136.
Ministério da Saúde (BR). Secretaria de Vigilância em Saúde. Departamento de Vigilância das Doenças Transmissíveis. Diretrizes para vigilância, atenção e eliminação da Hanseníase como problema de saúde pública: manual técnico-operacional [recurso eletrônico]. Brasília: Ministério da Saúde; 2016.
Ministério da Saúde (BR). Secretaria de Vigilância em Saúde. Departamento de Vigilância das Doenças Transmissíveis. Guia prático sobre a hanseníase. Brasília: Ministério da Saúde; 2017
Instituto Brasileiro de Geografia e Estatística. Estados: Tocantins. 2019. [updated 2017; cited 8 jan. 2020]. Available from: https://cidades.ibge.gov.br/brasil/to/panorama
PALMAS. Portaria Conjunta SEMUS/FESP nº 257 DE 23 de março de 2016. Institui o Projeto “Palmas Livre da Hanseníase”, no âmbito da ges- tão municipal do SUS. Disponível em: http://fesp.palmas.to.gov.br/moodle/mod/folder/view.php?id=39. Acesso em: 20 abr. 2019.
Imbiriba EN, Silva AL Neto, Souza WV, Pedrosa V, Cunha MG, Garnelo L. Social inequality, urban growth and leprosy in Manaus: a spatial approach. Rev Saúde Pública. 2009;43(4):656-65.
Moschioni C, Antunes CMF, Grossi MAF, Lambertucci JR. Risk factors for physical disability at diagnosis of 19,283 new cases of leprosy. Rev Socied Bras Med Trop. 2010;43(1):19-22.
Monteiro LD, Alencar CHM, Barbosa JC, Braga KP, Castro MDM, Heukelbach J. Incapacidades físicas em pessoas acometidas pela hanseníase no período pós-alta da poliquimioterapia em um município no norte do Brasil. Cad Saúde Pública. 2013;29(5):909-20.
Brito AL, Monteiro LD, Ramos NA Junior, Heukelbach J, Alencar CH. Tendencia temporal da hanseníase em uma capital do Nordeste do Brasil: epidemiologia e análise por pontos de inflexão, 2001 a 2012. Rev Bras Epidemiol. 2016;19(1):194-204. doi: http://dx.doi.org/10.1590/1980-5497201600010017.
Monteiro LD, Mota RMS, Martins-Melo FR, Alencar CH, Heukelbach J. Determinantes sociais da hanseníase em um estado hiperendêmico da região Norte do Brasil. Rev Saude Publica. 2017;51:70. doi:https://doi.org/10.1590/S1518-8787.2017051006655
Pires CAA, Malcher CMSR, Abreu JMC Junior, Albuquerque TG, Correa IRS, Daxbacher ELR. Hanseníase em menores de 15 anos: a importância do exame de contato. Rev Paul Pediatria. 2012;30(2):292-5.
Opromolla DVA. Noções de hansenologia. Bauru: Centro de Estudos Dr. Reynaldo Quagliato; 2000.
Talhari S, Neves RG, Penna GO, Oliveira MLW. Dermatologia tropical: Hanseníase. 4a ed. Manaus: Fundação Medicina Tropical; 2006.
Sachdeva S, Amin SS, Khan Z, Sharma PK, Bansal S. Childhood leprosy: lest we forget. J Trop Doctor. 2011; 41:163-5.
Jain S, Reddy RG, Osmani SN, Lockwood DN, Suneetha S. Childhood leprosy in an urban clinic, Hyderabad, India: clinical presentation and the role of household contacts. Lepr Rev. 2002;73:248-53.
Barreto JG, Bisanzio D, Guimarães LS, Spencer JS, Vazquez-Prokopec GM, Kitron U et al. Spatial analysis spotlighting early childhood leprosy transmission in a hyperendemic municipality of the Brazilian Amazon Region. PLoS Negl Trop. Dis. 2014;8(2):e 2665. doi: https://doi.org/10.1371/journal.pntd.0002665.
Singal A, Sonthalia S, Pandhi D. Childhood leprosy in a tertiary-care hospital in Delhi, India: a reappraisal in the post-elimination era. Lepr Rev. 2011;82:259-69.
Ganapati R, Naik SS, Pandya SS. Childhood leprosy - study of prevalence rates and clinical aspects through surveys in Bombay. Lepr India. 1976;48(4Supl):645-60
Romero-Montoya IM, Beltrán-Alzate J, Ortiz-Marín D, Cardona-Castro N. Leprosy in Colombian children and adolescents. Ped Infec Dis Journal. 2014. 33(3):321-2. [cited 18 dez. 2018]. Available from: https://insights.ovid.com/crossref?an=00006454-201403000-00028.
Moet, FJ, Pahan D, Oskam L, Richardus JH, COLEP Study Group. Effectiveness of single dose rifampicin in preventing leprosy in close contacts of patients with newly diagnosed leprosy: cluster randomized controlled trial. BMJ. 2008;336(7647):761-4. doi: 10.1136/bmj.39500.885752.BE. Epub 2008 Mar 10.
Ezenduka C, Post E, John S, Suraj A, Namadi A, Onwujekwe O. Cost-effectiveness analy-sis of three leprosy case detection methods in Northern Nigeria. PLoS Negl Trop Dis. 2012;6(9):e1818. doi: https://doi.org/10.1371/journal.pntd.0001818.
Fine PE, Sterne JA, Pönnighaus JM, Bliss L, Saui J, Chihana A. Household and dwell-ing contact as risk factors for leprosy in north-ern Malawi. Am J Epidemiol. 1997;146(1):91-102. doi: https://doi.org/10.1093/oxfordjournals.aje.a009195
Swain JP, Mishra S, Jena S. Prevalence of lep-rosy among household contacts of leprosy cases in western Orissa. Indian J Lepr. 2004;76(1):19-29.
Doull JA, Rodriguez JN, Gunito R, Plantilla FC. A field study of leprosy in Cebu. Int J Lepr. 1936;4(2):141–70
Sansarricq H. (Coord). La Lepre. Paris: Ellipdrd; 1995.
Santos, SD, Penna GO, Costa MCN, Natividade MS, Teixeira MG. Leprosy in children and adolescents under 15 years old in an urban centre in Brazil. Mem Inst Oswaldo Cruz. 2016;111(6)-359-64. doi: http://dx.doi.org/10.1590/0074-02760160002.
Merle CSC, Cunha SS, Rodrigues LC. BCG vaccination and leprosy protection: review of current evidence and status of BCG in leprosy control. Expert Rev Vaccines. 2010;9(2):209-22.
Bechelli LM, Rotberg A. Compêndio de leprologia. Rio de Janeiro: Ministério da Saúde/SNL; 1956
Scollard DM, Adams LB, Gillis TP, Krahenbuhl JL, Truman RW, WilIiams DL. The continuing challenges of leprosy. Clin. Microbio. Rev. 2006;19(2):338-81. doi: http://dx.doi.org/10.1128/CMR.19.2.338-381.2006
Convit J, Borges R, Ulrich M, Aranzazu N, Pinardi ME, Parra JJ. Leprosy vaccines. Hansenol Int. 2003;28(1):13-8
Cunha SS, Alexander N, Barreto ML, Pereira ES, Dourado I. BCG revaccination does not protect against leprosy in the Brazilian Amazon: a cluster randomised trial. PLOS Neglected Tropical Diseases. 2008;2(2):e167. doi: https://doi.org/10.1371/journal.pntd.0000167
Rabello FE. Clinical aspects: The polar concept. In: Latapi F, Saúl A, Rodríguez O, Browne SG. Leprosy. Proceedings of the XI International Leprosy Congress. Amsterdam: Excerpta Médica; 1978. p. 63-7.
This journal is licensed under a Creative Commons Attribution 4.0 International License.
Downloads
